INVICTUS ANNOUNCES A
INVICTUS ANNOUNCES APPOINTMENT OF INTERIM CEO AND ALTERNATE DIRECTOR
October 08, 2019 09:00 ET | Invictus
Vancouver, B.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that,...
INVICTUS CLOSES SALE
INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS
September 24, 2019 09:00 ET | Invictus
Vancouver, B.C., Sept. 24, 2019 (GLOBE NEWSWIRE) --   Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the...
INVICTUS ENTERS INTO
INVICTUS ENTERS INTO AGREEMENT TO SELL FUTURE HARVEST DEVELOPMENT LTD.
September 20, 2019 12:07 ET | Invictus
Vancouver, B.C., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 20, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces...
INVICTUS ANNOUNCES A
INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE
September 11, 2019 09:00 ET | Invictus
Vancouver, B.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 11, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to...
INVICTUS SELLS 09895
INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS
August 30, 2019 17:30 ET | Invictus
Vancouver, B.C., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces...
ACREAGE PHARMS LTD.
ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL
August 27, 2019 17:25 ET | Invictus
Vancouver, B.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 27, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to...
ACREAGE PHARMS LTD.
ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE
August 14, 2019 09:00 ET | Invictus
Vancouver, B.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor...
GENE SIMMONS ABDICAT
GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS
August 12, 2019 09:00 ET | Invictus
Vancouver, B.C., Aug. 12, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing and...
ACREAGE PHARMS LTD.
ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY
August 06, 2019 09:00 ET | Invictus
Vancouver, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon,...
Invictus announces A
Invictus announces Annual General Meeting Results
July 25, 2019 15:03 ET | Invictus
Vancouver, British Columbia, July 25, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, July 25, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is...